NORTHERN TRUST CORP - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 152 filers reported holding THERAPEUTICSMD INC in Q2 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$1,344,000
+2.9%
3,536,676
-3.9%
0.00%
Q4 2021$1,306,000
-57.0%
3,680,453
-10.3%
0.00%
-100.0%
Q3 2021$3,040,000
-34.4%
4,101,996
+5.3%
0.00%0.0%
Q2 2021$4,636,000
-6.9%
3,895,950
+4.8%
0.00%0.0%
Q1 2021$4,979,000
+41.9%
3,716,095
+28.2%
0.00%0.0%
Q4 2020$3,508,000
-21.2%
2,899,058
+2.9%
0.00%0.0%
Q3 2020$4,450,000
+20.5%
2,816,198
-4.7%
0.00%0.0%
Q2 2020$3,693,000
+30.0%
2,954,873
+10.3%
0.00%0.0%
Q1 2020$2,840,000
-56.3%
2,679,739
-0.3%
0.00%0.0%
Q4 2019$6,506,000
-45.3%
2,688,780
-18.0%
0.00%
-66.7%
Q3 2019$11,898,000
+94.2%
3,277,621
+39.1%
0.00%
+200.0%
Q2 2019$6,127,000
-46.1%
2,356,244
+0.9%
0.00%
-66.7%
Q1 2019$11,377,000
+30.3%
2,336,109
+2.0%
0.00%
+50.0%
Q4 2018$8,729,000
-42.2%
2,290,649
-0.6%
0.00%
-50.0%
Q3 2018$15,112,000
+16.1%
2,303,755
+10.4%
0.00%
+33.3%
Q2 2018$13,021,000
+33.3%
2,086,552
+4.0%
0.00%0.0%
Q1 2018$9,768,000
-19.6%
2,005,490
-0.3%
0.00%0.0%
Q4 2017$12,151,000
+18.1%
2,011,731
+3.4%
0.00%0.0%
Q3 2017$10,293,000
-5.2%
1,945,907
-5.5%
0.00%0.0%
Q2 2017$10,858,000
-19.3%
2,060,175
+10.3%
0.00%
-25.0%
Q1 2017$13,449,000
+32.0%
1,868,096
+5.8%
0.00%
+33.3%
Q4 2016$10,191,000
-14.3%
1,766,237
+1.2%
0.00%
-25.0%
Q3 2016$11,888,000
-19.4%
1,745,816
+0.6%
0.00%
-20.0%
Q2 2016$14,757,000
+40.2%
1,736,096
+5.5%
0.01%
+66.7%
Q1 2016$10,528,000
-30.9%
1,645,073
+12.0%
0.00%
-40.0%
Q4 2015$15,237,000
+84.2%
1,469,337
+4.1%
0.01%
+66.7%
Q3 2015$8,272,000
-19.4%
1,411,578
+8.1%
0.00%0.0%
Q2 2015$10,264,000
+42.3%
1,306,003
+9.6%
0.00%
+50.0%
Q1 2015$7,213,000
+41.0%
1,192,138
+3.7%
0.00%0.0%
Q4 2014$5,114,000
-7.3%
1,149,186
-3.4%
0.00%0.0%
Q3 2014$5,519,000
+27.2%
1,189,443
+21.1%
0.00%
+100.0%
Q2 2014$4,340,000
-36.4%
981,961
-9.2%
0.00%
-50.0%
Q1 2014$6,825,000
+19.0%
1,081,688
-1.7%
0.00%0.0%
Q4 2013$5,733,000
+117.2%
1,100,589
+22.2%
0.00%
+100.0%
Q3 2013$2,640,000
+228.0%
900,893
+238.8%
0.00%
Q2 2013$805,000265,9330.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q2 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders